Commission Implementing Decision (EU) 2025/2390 of 28 November 2025 concerning the extension of the action taken by the Health and Safety Executive of the United Kingdom permitting the making available on the market and use of the biocidal products Contrac Blox and Roban Oktablok in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2025) 8051)